Safety of inactivated SARS-CoV-2 vaccines in myasthenia gravis: A survey-based study: Background Vaccination remains the most effective measure to prevent SARS-CoV-2 infection and worse outcomes. However, many myasthenia gravis #immunology… https://t.co/7
Safety of inactivated SARSCoV2 vac in myasthenia gravis: Precipitating factors might contribute to worsening in some. Logistic regression revealed only interval since the last aggravation ≤6mth asso with worsening after SARSCoV2 vac (P = 0.01, OR = 8.62) h
New Research: Safety of inactivated SARS-CoV-2 vaccines in myasthenia gravis: A survey-based study: Background Vaccination remains the most effective measure to prevent SARS-CoV-2 infection and worse outcomes. However, many myasthenia gravis… https://t.co